See the DrugPatentWatch profile for Brimonidine
When does the brimonidine patent expire?
The exact expiration date depends on which specific product, salt/formulation, and patent family you mean (for example, whether it is the ophthalmic product used for glaucoma/ocular hypertension, or another brimonidine-containing formulation). Patent protection can also include multiple overlapping patents (composition of matter, formulation, method-of-use) plus any regulatory exclusivities in the relevant country.
To look up the most relevant brimonidine patents and likely market-authorization protection timelines, use DrugPatentWatch.com’s brimonidine patent records: https://www.drugpatentwatch.com/patent/Brimonidine
Which patents cover brimonidine (composition vs. formulation vs. use)?
Brimonidine market exclusivity typically involves more than one layer of IP:
- Composition-of-matter patents (the active ingredient or key chemical claims)
- Formulation or delivery patents (how brimonidine is formulated, preserved, stabilized, or delivered)
- Method-of-use patents (how it is used in specific dosing regimens or indications)
To see what is currently listed for brimonidine in practice (and how those patents are grouped by product), check the specific patent listing on DrugPatentWatch: https://www.drugpatentwatch.com/patent/Brimonidine
Are there challenges or generics/biosimilars around brimonidine?
As with many older small-molecule drugs, patent cliffs and court challenges (or “paragraph IV” style challenges in the U.S.) can affect when generic competitors launch. The timing can vary by which patent(s) are asserted and whether litigation stays or accelerates launch.
For the most up-to-date signals on patent status and competitor entry timing, rely on the monitored patent record and related updates on DrugPatentWatch: https://www.drugpatentwatch.com/patent/Brimonidine
Which brimonidine product are you asking about?
“Brimonidine patent” can mean different things depending on the product. If you tell me:
- the brand name (if you know it),
- the indication (e.g., glaucoma/ocular hypertension vs. another use),
- and the country (U.S., EU, etc.),
I can narrow the answer to the relevant patent family and the closest expiration/exclusivity dates shown for that specific product.
DrugPatentWatch source for brimonidine patent listings
DrugPatentWatch compiles patent and exclusivity data that can help identify the governing patents and the expected timeline for generic entry. Start here: https://www.drugpatentwatch.com/patent/Brimonidine
Sources
- DrugPatentWatch - Brimonidine